-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Tigloylgomisin P
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/69176-51-8.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 69176-51-8 |
| Description | Tigloylgomisin P is purified from the stems of Schisandra pubescens. Schizandrer B shows moderate to marginal cytotoxicity against A549, PC-3, KB and KBvin human cancer cell lines. |
Product Information
| Synonyms | Schizandrer B |
| Molecular Weight | 514.57 |
| Molecular Formula | C28H34O9 |
| Canonical SMILES | CC=C(C)C(=O)OC1C2=CC(=C(C(=C2C3=C(C4=C(C=C3CC(C1(C)O)C)OCO4)OC)OC)OC)OC |
| InChI | InChI=1S/C28H34O9/c1-9-14(2)27(29)37-26-17-12-18(31-5)22(32-6)25(34-8)21(17)20-16(10-15(3)28(26,4)30)11-19-23(24(20)33-7)36-13-35-19/h9,11-12,15,26,30H,10,13H2,1-8H3/b14-9+/t15-,26+,28+/m0/s1 |
| InChIKey | BKGUPIVDQHHVMV-TWJXSMCESA-N |
| Purity | 98.5% |
| Solubility | Soluble in Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc. |
| Appearance | Powder |
| Storage | -20°C, sealed storage, away from moisture and light * In solvent : -80°C 6 months; -20°C 1 month (sealed storage, away from moisture and light) |
| Complexity | 833 |
| Exact Mass | 514.22028266 |
| In Vitro | Tigloylgomisin P displays weak cytotoxicity against A549 cells (GI50=18.77 μM), epidermoid carcinoma of the nasopharynx (KB; GI50=13.91 μM). |
| PSA | 101.91000 |
| Target | HIV |
| XLogP3-AA | 4.6 |
